Development of case vignettes for assessment of the inter-rater variability of national validation teams for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals
van Hauwermeiren, E., Iosifidis, E., Kärki, T., Suetens, C., Kinross, P., Plachouras, D.
ECDC, EFSA and EMA Joint Scientiﬁc Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals
ECDC, EFSA and EMA have jointly established a list of harmonised outcome indicators to assist EU Member States in assessing their progress in reducing the use of antimicrobials and antimicrobial resistance (AMR) in both humans and food-producing animals.
ECDC welcomes the endorsement of the global action plan on antimicrobial resistance by the World Health Assembly
By endorsing the new global action plan endorsed at the World Health Assembly, WHO Member States agreed to mobilise resources to ensure its implementation and committed to have similar plans at national level by 2017.
EFSA/ECDC European Union summary report on antimicrobial resistance in zoonotic indicator bacteria from humans, animals and food in 2013
The antimicrobial resistance data on zoonotic and indicator bacteria in 2013, submitted by 28 EU Member States, were jointly analysed by EFSA and ECDC.
ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals
The ECDC, the EFSA and the EMA have for the first time jointly explored associations between consumption of antimicrobials in humans and food-producing animals, and antimicrobial resistance in bacteria from humans and food-producing animals.
Trends of antimicrobial consumption in the community and in the hospital sector across Europe
ECDC published the third annual report of the European Surveillance of Antimicrobial Consumption Network (ESAC-Net).
Antimicrobial resistance surveillance in Europe 2012
This report presents antimicrobial resistance data for seven microorganisms of major public health importance: Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, Acinetobacter species, Streptococcus pneumoniae, Staphylococcus aureus, and Enterococci.
Carbapenemase-producing Enterobacteriaceae continue to spread in Europe
Carbapenemase-producing Enterobacteriaceae (CPE) are an emerging threat to healthcare. Beside the carbapenems – a last-line class of antibiotics – CPE are resistant to most other antibiotics, leaving few options for the treatment of infected patients. In an effort to assess the nature and scale of CPE spread in Europe, a group of European experts is implementing the European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE).
Antimicrobial resistance surveillance in Europe 2011
This report presents antimicrobial resistance data for seven invasive pathogens of major public health importance: Streptococcus pneumoniae, Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae and Pseudomonas aeruginosa.